“Metabolic Activation and Inactivation of Irinotecan When Combined With the Human Monoclonal Antibody Bevacizumab”. Journal of Analytical Oncology, vol. 2, no. 4, Dec. 2013, pp.  218-225, https://doi.org/10.6000/1927-7229.2013.02.04.4.